NDC 0456-1214

Namzaric

Memantine Hydrochloride And Donepezil Hydrochloride

Namzaric is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Memantine Hydrochloride; Donepezil Hydrochloride.

• Product ID: 0456-1214_1269b010-9726-45ea-b191-dd124c5ec400
• NDC: 0456-1214
• Product Type: Human Prescription Drug
• Proprietary Name: Namzaric
• Generic Name: Memantine Hydrochloride And Donepezil Hydrochloride
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2014-12-24
• Marketing Category: NDA / NDA
• Application Number: NDA206439
• Labeler Name: Allergan, Inc.
• Substance Name: MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE
• Active Ingredient Strength: 14 mg/1; mg/1
• Pharm Classes: NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0456-1214-11

10 CAPSULE in 1 BLISTER PACK (0456-1214-11)

• Marketing Start Date: 2014-12-24
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0456-1214-11 [00456121411]

Namzaric CAPSULE

• Marketing Category: NDA
• Application Number: NDA206439
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-12-24

NDC 0456-1214-30 [00456121430]

Namzaric CAPSULE

• Marketing Category: NDA
• Application Number: NDA206439
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2014-12-24

NDC 0456-1214-63 [00456121463]

Namzaric CAPSULE

• Marketing Category: NDA
• Application Number: NDA206439
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2015-09-02

NDC 0456-1214-90 [00456121490]

Namzaric CAPSULE

• Marketing Category: NDA
• Application Number: NDA206439
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-12-24

Drug Details

Active Ingredients

Ingredient	Strength
MEMANTINE HYDROCHLORIDE	14 mg/1

OpenFDA Data

• SPL SET ID: 90fedc32-19e5-480c-afc6-f35a5cf4b9aa
• Manufacturer:
  • Allergan, Inc.
• UNII:
  • 3O2T2PJ89D
  • JY0WD0UA60
• RxNorm Concept Unique ID - RxCUI:
  • 1602594
  • 1805425
  • 1858971
  • 1602588
  • 1805427
  • 1599805
  • 1599803
  • 1805422
  • 1805420
  • 1858970
• UPC Code:
  • 0304561214303
  • 0304561207305
  • 0304561228300
  • 0304561221301

Pharmacological Class

• NMDA Receptor Antagonists [MoA]
• N-methyl-D-aspartate Receptor Antagonist [EPC]
• Cholinesterase Inhibitor [EPC]
• Cholinesterase Inhibitors [MoA]
• NMDA Receptor Antagonists [MoA]
• N-methyl-D-aspartate Receptor Antagonist [EPC]
• Cholinesterase Inhibitor [EPC]
• Cholinesterase Inhibitors [MoA]

NDC Crossover Matching brand name "Namzaric" or generic name "Memantine Hydrochloride And Donepezil Hydrochloride"

NDC	Brand Name	Generic Name
0456-1207	Namzaric	memantine hydrochloride and donepezil hydrochloride
0456-1214	Namzaric	memantine hydrochloride and donepezil hydrochloride
0456-1221	Namzaric	memantine hydrochloride and donepezil hydrochloride
0456-1228	Namzaric	memantine hydrochloride and donepezil hydrochloride
0456-1229	Namzaric	memantine hydrochloride and donepezil hydrochloride